rhodamine 123 has been researched along with Neurodegenerative Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Badiali, L; Benassi, R; Bondioli, L; Fano, RA; Forni, F; Rivasi, F; Ruozi, B; Tosi, G; Vandelli, MA | 1 |
| Audus, KL; Georg, G; Liu, Y; Michaelis, ML; Rice, A; Turunen, B | 1 |
2 other study(ies) available for rhodamine 123 and Neurodegenerative Diseases
| Article | Year |
|---|---|
Investigation on mechanisms of glycopeptide nanoparticles for drug delivery across the blood-brain barrier.
Topics: Animals; Blood-Brain Barrier; Drug Delivery Systems; Glycopeptides; Lactic Acid; Loperamide; Male; Nanoparticles; Neurodegenerative Diseases; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Wistar; Rhodamine 123; Tissue Distribution | 2011 |
Overcoming the blood-brain barrier to taxane delivery for neurodegenerative diseases and brain tumors.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding Sites; Blood-Brain Barrier; Brain Neoplasms; Cells, Cultured; Dose-Response Relationship, Drug; Drug Delivery Systems; Drug Design; Endothelial Cells; Male; Microtubules; Molecular Conformation; Neurodegenerative Diseases; Neurofibrillary Tangles; Paclitaxel; Rats; Rats, Sprague-Dawley; Rhodamine 123; Succinic Acid; Taxoids | 2003 |